S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
S&P 500   3,841.47
DOW   30,996.98
QQQ   325.42
Log in

Sartorius Aktiengesellschaft (SRT3.F) Stock Forecast, Price & News

+8.40 (+2.24 %)
(As of 01/22/2021 12:00 AM ET)
Today's Range
Now: €383.00
50-Day Range
MA: €355.08
52-Week Range
Now: €383.00
Volume58,264 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers live cell analysis system, and cell analysis reagents and consumables; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. It also provides lab filtration and purification devices; sterile and virus filtration, crossflow filtration, harvesting, prefiltration, membrane chromatography, air/gas filtration, and integrity testing devices; and liquid storage and shipping, freeze and thaw, mixing, proven integrity, transferring and sampling, connecting and disconnecting, and final filling management products. In addition, the company offers process control and data analytics products, such as process analyzers, automation modules, and data analytics and chemometrics; and microbiology products, and lab water purification systems. Further, it provides lab balances, mass comparators and metrology, moisture analyzers, specialty weighing solutions, weighing accessories, weights/weight sets, paint mixing solutions, and OEM weigh cells; and OEM membrane and device, pipetting and dispensing, and connectivity solutions. Additionally, the company offers bioprocess development engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, cannabis testing, food and beverage, environmental, and paint mixing industries. Sartorius Aktiengesellschaft and Evotec SE has a partnership with Curexsys GmbH on iPSC-based therapeutic exosome approach. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Sartorius Aktiengesellschaft (SRT3.F) logo


Overall MarketRank

0.59 out of 5 stars

Analyst Opinion: 1.1Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Diagnostics & Research



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable
+8.40 (+2.24 %)
(As of 01/22/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SRT3 News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT3 and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Sartorius Aktiengesellschaft (SRT3.F) (FRA:SRT3) Frequently Asked Questions

How has Sartorius Aktiengesellschaft (SRT3.F)'s stock price been impacted by COVID-19 (Coronavirus)?

Sartorius Aktiengesellschaft (SRT3.F)'s stock was trading at €199.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SRT3 shares have increased by 92.5% and is now trading at €383.00.
View which stocks have been most impacted by COVID-19

Is Sartorius Aktiengesellschaft (SRT3.F) a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sartorius Aktiengesellschaft (SRT3.F) in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Sartorius Aktiengesellschaft (SRT3.F) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SRT3, but not buy additional shares or sell existing shares.
View analyst ratings for Sartorius Aktiengesellschaft (SRT3.F)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Sartorius Aktiengesellschaft (SRT3.F)?

Wall Street analysts have given Sartorius Aktiengesellschaft (SRT3.F) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sartorius Aktiengesellschaft (SRT3.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for SRT3?

9 equities research analysts have issued twelve-month price targets for Sartorius Aktiengesellschaft (SRT3.F)'s shares. Their forecasts range from €212.00 to €373.00. On average, they anticipate Sartorius Aktiengesellschaft (SRT3.F)'s share price to reach €321.89 in the next year. This suggests that the stock has a possible downside of 16.0%.
View analysts' price targets for Sartorius Aktiengesellschaft (SRT3.F)
or view Wall Street analyst' top-rated stocks.

Who are some of Sartorius Aktiengesellschaft (SRT3.F)'s key competitors?

What other stocks do shareholders of Sartorius Aktiengesellschaft (SRT3.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Aktiengesellschaft (SRT3.F) investors own include NVIDIA (NVDA), QUALCOMM (QCOM), Texas Instruments (TXN), Abbott Laboratories (ABT), Accenture (ACN), Alliance Data Systems (ADS), Allianz SE (ALV.F) (ALV), BASF SE (BAS.F) (BAS), Daimler AG (DAI.F) (DAI) and Henkel AG & Co. KGaA (HEN3.F) (HEN3).

Who are Sartorius Aktiengesellschaft (SRT3.F)'s key executives?

Sartorius Aktiengesellschaft (SRT3.F)'s management team includes the following people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 55, Pay $1.62M)
  • Mr. Rainer Lehmann, CFO, Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 44, Pay $710k)
  • Mr. John Gerard Mackay, Head of Lab Products & Services Division and Member of Exec. Board (Age 58, Pay $779k)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 45, Pay $649k)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 51, Pay $56k)
  • Mr. Manfred Werner, Sr. VP of Admin. Organization & Auditing
  • Ms. Mei Wang, Head of Production - China
  • Ms. Patricia Spannagel, Head of Quality Assurance - Mechatronics Division Goettingen
  • Mr. Rashid Maqbool, Head of Production & Certification Department - Denver USA
  • Mr. Manohar Kuppusami, Head of Production Department - India

What is Sartorius Aktiengesellschaft (SRT3.F)'s stock symbol?

Sartorius Aktiengesellschaft (SRT3.F) trades on the FRA under the ticker symbol "SRT3."

What is Sartorius Aktiengesellschaft (SRT3.F)'s stock price today?

One share of SRT3 stock can currently be purchased for approximately €383.00.

What is Sartorius Aktiengesellschaft (SRT3.F)'s official website?

The official website for Sartorius Aktiengesellschaft (SRT3.F) is www.sartorius.de.

How can I contact Sartorius Aktiengesellschaft (SRT3.F)?

Sartorius Aktiengesellschaft (SRT3.F)'s mailing address is Weender Landstrasse 94-108, GOETTINGEN, 37075, Germany. The company can be reached via phone at +49-551-3080.

This page was last updated on 1/24/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.